- About
- Home
- Introduction
- Statistics
- Programs
- Dignet
- Gene
- GenePair
- BioSummarAI
- Help & Docs
- Documents
- Help
- FAQs
- Links
- Acknowledge
- Disclaimer
- Contact Us
Gene Information
Gene symbol: JARID1B
Gene name: jumonji, AT rich interactive domain 1B
HGNC ID: 18039
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | CD44 | 1 hits |
| 2 | CLOCK | 1 hits |
| 3 | CSAG1 | 1 hits |
| 4 | CTAGE1 | 1 hits |
| 5 | CTDSP1 | 1 hits |
| 6 | DDX43 | 1 hits |
| 7 | DDX53 | 1 hits |
| 8 | DLK1 | 1 hits |
| 9 | DNAH17 | 1 hits |
| 10 | PASD1 | 1 hits |
| 11 | PIAS2 | 1 hits |
| 12 | PRAME | 1 hits |
| 13 | PROM1 | 1 hits |
| 14 | SPA17 | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 14639620 | Patients had been treated within 2 clinical trials with autologous tumor cells gene-modified for IL-7 or IL-12. |
| 2 | 14639620 | Besides 2 known cancer-germline genes (SCP-1 and PLU-1), the other isolated antigens were expressed in a non-tumor-specific fashion as analyzed by virtual Northern blot or RT-PCR. |
| 3 | 14639620 | The properties of homologues to several of the identified tumor-antigens, especially PLU-1, SCP-1, DNEL2, CLOCK, and PIASx-alpha, suggest further investigation of their possible function in malignant melanoma. |
| 4 | 14639620 | Patients had been treated within 2 clinical trials with autologous tumor cells gene-modified for IL-7 or IL-12. |
| 5 | 14639620 | Besides 2 known cancer-germline genes (SCP-1 and PLU-1), the other isolated antigens were expressed in a non-tumor-specific fashion as analyzed by virtual Northern blot or RT-PCR. |
| 6 | 14639620 | The properties of homologues to several of the identified tumor-antigens, especially PLU-1, SCP-1, DNEL2, CLOCK, and PIASx-alpha, suggest further investigation of their possible function in malignant melanoma. |
| 7 | 20726502 | The broadest mRNA expression profiles were observed for the following eight CT genes: Sp17 (25/25), PRAME (25/25), CSAGE (24/25), PASD1 (22/25), CAGE/DDX53 (19/25), CTAGE1 (19/25), HAGE/DDX43 (16/25) and PLU-1/JARID1B (15/25). |
| 8 | 23896726 | Here we identified the NOTCH antagonist delta-like 1 homologue (DLK1) as a vascular pericyte-associated antigen expressed in renal cell carcinomas (RCC), but not in normal kidney tissues in mice and humans. |
| 9 | 23896726 | After therapeutic vaccination, tumors displayed increased prevalence of activated VCAM1(+)CD31(+) vascular endothelial cells (VECs) and CXCL10, a type-1 T cell recruiting chemokine, in concert with increased levels of type-1 CD8(+) tumor-infiltrating lymphocytes (TIL). |
| 10 | 23896726 | Vaccination against DLK1 also yielded (i) dramatic reductions in Jarid1B(+), CD133(+), and CD44(+) (hypoxia-responsive) stromal cell populations, (ii) enhanced tumor cell apoptosis, and (iii) increased NOTCH signaling in the TME. |